Radiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer
ConditionRadiotherapy; Complications
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorGuizhou Medical University
About this trial
The aim of this randomized study is to investigate local tumor control,survival outcomes and complications on patients of liver metastasis in small cell lung cancer.
Eligibility criteria
Qualifiers
Informed consent (radiation, medication) before treatment;
Age 18 to 70 years old,regardless of gender;
Initial SCLC confirmed by histopathological or cytological examination;
Metastatic lesions in the distant area: included liver metastasis；
Disqualifiers
patients with history of mental illness;
patients combined with other malignancies;
Active period of disease caused by bacteria, fungi or viruses; and these severe infection requiring intravenous antibiotics,antifungal or antiviral therapy;
Patients with serious cardiovascular disease ,including uncontrolled hypertension, unstable angina,history of myocardial infarction within the past 12 months,and severe arrhythmias.
Trial design
Treatments tested in this trial
- Radiotherpy will be performed to thoracic and liver metastasis after chemotherapy.
Treatment groups
66 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov